Covidien inks $2.6 billion buyout of ev3

June 1, 2010 by MassDevice staff

Covidien plc expands its peripheral vascular footprint with a $2.6 billion acquisition of ev3 Inc.

COV, EVVV logos

Covidien plc (NYSE:COV) agreed to acquire ev3 Inc. (NSDQ:EVVV) for about $2.6 billion in cash in a move that substantially expands its footprint in the peripheral vascular market.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp